Keep container tightly closed in a dry and well-ventilated place.

Non-hazardous for transport.

Effect of an Antiretroviral Regimen Containing Ritonavir Boosted Lopinavir on Intestinal and Hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected Patients: C Wyen¹, U Fuhr², D Frank², RE Aarnoutse³, T Klaassen², A Lazar², A Seeringer⁴, O Doroshyenko², JC Kirchheiner⁴, F Abdulrazik¹, N Schmeisser¹, C Lehmann¹, W Hein⁵, E Schömig², DM Burger³, G Fätkenheuer¹ and A Jetter^2,6; Author Affliations: ¹Department of Internal Medicine, Hospital of the University of Cologne, Köln, Germany; ²Department of Pharmacology, Clinical Pharmacology, University of Cologne, Köln, Germany; ³Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; ⁴Department of Pharmacology of Natural Products and Clinical Pharmacology, University of Ulm, Germany; ⁵Department of Clinical Chemistry, Hospital of the University of Cologne, Köln, Germany; ⁶Division of Clinical Pharmacology and Toxicology, Department of Internal Medicine, University Hospital Zürich, Zürich, Switzerland